GLAXOSMITHKLINE PHARMACEUTICALS
|
The Current P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 10.96.
| Share Price | ₹2,398.7 | Jan 12,2026 |
| Market Cap | ₹40,633.1 Cr | |
| Sales-TTM | ₹3,708.9 Cr | TTM-Consolidated Results |
| Price/Sales | 10.96x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of GLAXOSMITHKLINE PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹40,633.1 Cr] as on Jan 12,2026
(/) Sales [ ₹3,708.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 10.96x ]
Thus, for GLAXOSMITHKLINE PHARMACEUTICALS , the investors are currently willing to pay '10.96 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLAXOSMITHKLINE PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLAXOSMITHKLINE PHARMACEUTICALS
PS Ratio Performance Analysis for GLAXOSMITHKLINE PHARMACEUTICALS
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 9.27x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's operated at median p/e ratio of 8.59x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 13x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 6.9x.
How does GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| GLAXOSMITHKLINE PHARMACEUTICALS | 3,708.9 | 10.96 | 40,633.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.58 | 416,728.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.17 | 172,248.0 |
| CIPLA LTD | 28,349.6 | 4.18 | 118,423.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.91 | 133,627.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.96 | 101,462.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.77 | 91,927.6 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.68 | 90,057.9 |
| LUPIN LTD | 24,750.7 | 4.04 | 100,028.0 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.09 | 68,107.7 |
| ABBOTT INDIA LTD | 6,714.4 | 8.99 | 60,378.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.09x |
| Max industry PS | 17.17x |
| Median industry PS | 6.77x |
| Average industry PS | 7.21x |
You may also like the below Video Courses